Buy ONCO by May 20, 2026.

ONCO is currently attracting attention not because of its original biotech business, but because of its aggressive transition into the AI humanoid robotics industry through its pending merger with Realbotix. In February 2026, ONCO announced a definitive agreement to acquire Realbotix LLC, a company focused on AI-powered humanoid robots for healthcare, hospitality, education, and customer service applications. This merger could completely transform ONCO from a struggling biotech company into a Nasdaq-listed AI robotics company at a time when global investor …